Journal of Pharmaceutical Sciences and Research

Journal Overview

The Journal of Pharmaceutical Sciences and Research (JPSR) is an international, peer-reviewed journal dedicated to the rapid publication of fundamental research papers on all areas of Pharmaceutical Sciences. JPSR is a quality-controlled, double-blind peer-reviewed, open-access journal, publishing high-quality research in the field of pharmaceutical sciences.

Our aim is to provide a platform for researchers, academics, professionals, and students to share their research findings and to explore contemporary issues and developments in the field of pharmaceutical science.

Scope

JPSR publishes original research articles, reviews, mini-reviews, short communications and notes on all areas of pharmaceutical sciences including:

Publication Frequency

JPSR is published monthly, with 12 issues per year. Special issues may be published on topics of particular interest.

Peer Review Process

All submitted manuscripts undergo initial screening by the editor to ensure alignment with the journal's scope and quality standards. Papers that meet these criteria are then subjected to double-blind peer review by at least two independent reviewers who are experts in the relevant field. The peer review process typically takes 4-6 weeks.

Conflict of Interest

The Journal of Pharmaceutical Sciences and Research requires authors to complete a disclosure form when submitting their manuscript. Authors must reveal any conflicts of interest or financial relationships that could influence the study’s findings—this includes employment, consultancy, ownership, honoraria, patent applications, or expert testimony. For industry-funded projects, it is crucial to clearly declare the extent of the sponsor's involvement. If the sponsor had no influence on the study's design, execution, analysis, or manuscript preparation, this must be explicitly stated. Upon acceptance, a Conflict of Interest statement will be included in the published article. The journal adheres to COPE guidelines on conflicts of interest and competing interests.

Plagiarism

Plagiarism involves presenting someone else's words, ideas, or expressions as if they are your own original work. This occurs when another person's content is used without proper acknowledgment, regardless of whether permission was obtained. The Journal of Pharmaceutical and Sciences and Research also recognizes "self-plagiarism" as a form of misconduct. Self-plagiarism refers to reusing parts of one’s previously published material in a new submission without appropriately citing the original source.

Open Access Policy

JPSR is an open access journal, which means that all content is freely available without charge to users or their institutions. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.

Retraction Policy

Pharmainfo Publication may retract articles in cases involving major errors, ethical issues, or fraudulent data in the published work. Retractions serve to uphold the accuracy and integrity of the scientific record. Common reasons for retraction include plagiarism, data falsification, ethical misconduct, duplicate submissions, and authorship disputes. Each retraction will be accompanied by a published notice explaining the reason, and in some cases, an explanation from the author may be required. The process follows the COPE Retraction Guidelines. For such matters, please contact jpsronline@gmail.com.

Indexing

JPSR is indexed in:

• SCOPUS (2009-2018)
• Chemical Abstracts Service (CAS)
• EMBASE (Elsevier)
• Google Scholar
• Index Copernicus
• Directory of Open Access Journals (DOAJ)

Ethics

JPSR adheres to the ethical guidelines for publication outlined by the Committee on Publication Ethics (COPE) . Authors, reviewers, and editors are expected to follow these standards to ensure the integrity of the academic record.

• ISSN (Online) 0975-1459
• Founded 2009
• Frequency Monthly

• Peer Reviewed

  Rigorous double-blind peer review process

• Open Access

  Free access to all published content

• Rapid Publication

  Quick review and publication process

• Wide Indexing

  Indexed in major databases